Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
Search insider filingsAll Congress filings
MORE TOOLS
WatchlistGold IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeSearch insider filingsAll Congress filings
More research tools
ExploreGold IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…

HomeSearchCongressWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
Back to Home
L

LGND

Nasdaq

LIGAND PHARMACEUTICALS INC

Latest disclosureOctober 6, 2026
Insider score Why 0?
0/ 100
Qualifying buys · 30d
$0

0 purchases · 74 sales

Price by TradingViewDelayed quote from TradingView, for viewing only. It does not power Whale Atlas scores or alerts. If the quote does not load, open the TradingView link.

Insider transactions 139

Limited filing history
All139Buying0Selling74Other65
Filters

Last 30 daysNo qualifying insider buying. Sales: $3.29M by 2 insiders.

65 of 139 trades · March 2, 2026 – October 2, 2026Incomplete history: this shows the filings imported so far, not every filing ever made. Dates are trade dates. Filters affect this table only.

Showing the first 6 of 65 trades on this page.

Exercise or conversion

Andrew Reardon

CLO & Secretary

Common Stock

Value context
$17.77K
Reported price
$52.27 / share
Traded October 2, 2026Filed October 6, 2026SEC filing
Exercise or conversion

Andrew Reardon

CLO & Secretary

Employee Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$52.27 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded October 2, 2026Filed October 6, 2026SEC filing
Tax or exercise withholding

Martine Zimmermann

Director

Common Stock

Value context
$34.33K
Reported price
$298.50 / share
Traded September 22, 2026Filed September 24, 2026SEC filing
Exercise or conversion

Octavio Espinoza

Chief Financial Officer

Common Stock

Value context
$854.9K
Reported price
$52.84 / share
Traded August 12, 2026Filed August 14, 2026SEC filing
Exercise or conversion

Octavio Espinoza

Chief Financial Officer

Common Stock

Value context
$145.26K
Reported price
$70.04 / share
Traded August 12, 2026Filed August 14, 2026SEC filing
Exercise or conversion

Octavio Espinoza

Chief Financial Officer

Common Stock

Value context
$159.95K
Reported price
$55.75 / share
Traded August 12, 2026Filed August 14, 2026SEC filing
Exercise or conversion

Octavio Espinoza

Chief Financial Officer

Common Stock

Value context
$410.32K
Reported price
$57.22 / share
Traded August 12, 2026Filed August 14, 2026SEC filing
Exercise or conversion

Octavio Espinoza

Chief Financial Officer

Common Stock

Value context
$230.14K
Reported price
$68.74 / share
Traded August 12, 2026Filed August 14, 2026SEC filing
Exercise or conversion

Octavio Espinoza

Chief Financial Officer

Employee Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$55.75 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded August 12, 2026Filed August 14, 2026SEC filing
Exercise or conversion

Octavio Espinoza

Chief Financial Officer

Employee Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$57.22 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded August 12, 2026Filed August 14, 2026SEC filing
Exercise or conversion

Octavio Espinoza

Chief Financial Officer

Non-Qualified Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$52.84 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded August 12, 2026Filed August 14, 2026SEC filing
Exercise or conversion

Octavio Espinoza

Chief Financial Officer

Non-Qualified Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$68.74 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded August 12, 2026Filed August 14, 2026SEC filing
Exercise or conversion

Octavio Espinoza

Chief Financial Officer

Non-Qualified Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$70.04 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded August 12, 2026Filed August 14, 2026SEC filing
Exercise or conversion

Jason Haas

Director

Common Stock

Value context
$316.48K
Reported price
$51.56 / share
Traded August 12, 2026Filed August 14, 2026SEC filing
Exercise or conversion

Jason Haas

Director

Non-Qualified Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$51.56 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded August 12, 2026Filed August 14, 2026SEC filing
Exercise or conversion

Andrew Reardon

CLO & Secretary

Common Stock

Value context
$261.35K
Reported price
$52.27 / share
Traded August 3, 2026Filed August 4, 2026SEC filing
Exercise or conversion

Andrew Reardon

CLO & Secretary

Employee Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$52.27 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded August 3, 2026Filed August 4, 2026SEC filing
Other activity disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Value context
$21.21K
Reported price
$160.7095 / share
Traded June 30, 2026Filed July 6, 2026SEC filing
Exercise or conversion

Andrew Reardon

CLO & Secretary

Common Stock

Value context
$261.35K
Reported price
$52.27 / share
Traded July 1, 2026Filed July 6, 2026SEC filing
Exercise or conversion

Andrew Reardon

CLO & Secretary

Employee Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$52.27 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded July 1, 2026Filed July 6, 2026SEC filing
Other activity disclosed

Octavio Espinoza

Chief Financial Officer

Common Stock

Value context
$2.73K
Reported price
$160.7095 / share
Traded June 30, 2026Filed July 6, 2026SEC filing
Other activity disclosed

Todd C. Davis

Chief Executive Officer

Common Stock

Value context
$21.21K
Reported price
$160.7095 / share
Traded June 30, 2026Filed July 6, 2026SEC filing
Exercise or conversion

Stephen L. Sabba

Director

Common Stock

Value context
$141.85K
Reported price
$66.13 / share
Traded June 16, 2026Filed June 18, 2026SEC filing
Exercise or conversion

Stephen L. Sabba

Director

Non-Qualified Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$66.13 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded June 16, 2026Filed June 18, 2026SEC filing
Exercise or conversion

Jason Haas

Director

Common Stock

Value context
$154.68K
Reported price
$51.56 / share
Traded June 12, 2026Filed June 15, 2026SEC filing
Exercise or conversion

Jason Haas

Director

Common Stock

Value context
$51.56K
Reported price
$51.56 / share
Traded June 12, 2026Filed June 15, 2026SEC filing
Exercise or conversion

Jason Haas

Director

Non-Qualified Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$51.56 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded June 12, 2026Filed June 15, 2026SEC filing
Exercise or conversion

Jason Haas

Director

Non-Qualified Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$51.56 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded June 12, 2026Filed June 15, 2026SEC filing
Award disclosed

Jason Aryeh

Director

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 5, 2026Filed June 12, 2026SEC filing
Award disclosed

Jason Aryeh

Director

Non-Qualified Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 5, 2026Filed June 12, 2026SEC filing
Award disclosed

Martine Zimmermann

Director

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 5, 2026Filed June 9, 2026SEC filing
Tax or exercise withholding

Martine Zimmermann

Director

Common Stock

Value context
$43.13K
Reported price
$237.00 / share
Traded June 5, 2026Filed June 9, 2026SEC filing
Award disclosed

Martine Zimmermann

Director

Non-Qualified Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 5, 2026Filed June 9, 2026SEC filing
Award disclosed

Stephen L. Sabba

Director

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 5, 2026Filed June 9, 2026SEC filing
Award disclosed

Stephen L. Sabba

Director

Non-Qualified Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 5, 2026Filed June 9, 2026SEC filing
Award disclosed

John L. Lamattina

Director

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 5, 2026Filed June 9, 2026SEC filing
Award disclosed

John L. Lamattina

Director

Non-Qualified Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 5, 2026Filed June 9, 2026SEC filing
Award disclosed

John W. Kozarich

Director

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 5, 2026Filed June 9, 2026SEC filing
Award disclosed

John W. Kozarich

Director

Non-Qualified Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 5, 2026Filed June 9, 2026SEC filing
Award disclosed

Jason Haas

Director

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 5, 2026Filed June 9, 2026SEC filing
Award disclosed

Jason Haas

Director

Non-Qualified Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 5, 2026Filed June 9, 2026SEC filing
Award disclosed

Nancy Ryan Gray

Director

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 5, 2026Filed June 9, 2026SEC filing
Award disclosed

Nancy Ryan Gray

Director

Non-Qualified Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 5, 2026Filed June 9, 2026SEC filing
Exercise or conversion

Andrew Reardon

CLO & Secretary

Common Stock

Value context
$261.35K
Reported price
$52.27 / share
Traded June 1, 2026Filed June 2, 2026SEC filing
Exercise or conversion

Andrew Reardon

CLO & Secretary

Employee Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$52.27 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded June 1, 2026Filed June 2, 2026SEC filing
Exercise or conversion

Octavio Espinoza

Chief Financial Officer

Common Stock

Value context
$48.61K
Reported price
$63.62 / share
Traded May 27, 2026Filed May 28, 2026SEC filing
Exercise or conversion

Octavio Espinoza

Chief Financial Officer

Common Stock

Value context
$51.36K
Reported price
$52.84 / share
Traded May 27, 2026Filed May 28, 2026SEC filing
Exercise or conversion

Octavio Espinoza

Chief Financial Officer

Employee Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$52.84 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded May 27, 2026Filed May 28, 2026SEC filing
Exercise or conversion

Octavio Espinoza

Chief Financial Officer

Employee Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$63.62 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded May 27, 2026Filed May 28, 2026SEC filing
Exercise or conversion

John W. Kozarich

Director

Common Stock

Value context
$31.91K
Reported price
$69.51 / share
Traded May 12, 2026Filed May 14, 2026SEC filing
Exercise or conversion

John W. Kozarich

Director

Common Stock

Value context
$109.48K
Reported price
$69.51 / share
Traded May 13, 2026Filed May 14, 2026SEC filing
Exercise or conversion

John W. Kozarich

Director

Non-Qualified Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$69.51 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded May 12, 2026Filed May 14, 2026SEC filing
Exercise or conversion

John W. Kozarich

Director

Non-Qualified Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$69.51 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded May 13, 2026Filed May 14, 2026SEC filing
Exercise or conversion

Andrew Reardon

CLO & Secretary

Common Stock

Value context
$261.35K
Reported price
$52.27 / share
Traded May 1, 2026Filed May 4, 2026SEC filing
Exercise or conversion

Andrew Reardon

CLO & Secretary

Employee Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$52.27 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded May 1, 2026Filed May 4, 2026SEC filing
Exercise or conversion

Andrew Reardon

CLO & Secretary

Common Stock

Value context
$261.35K
Reported price
$52.27 / share
Traded April 1, 2026Filed April 2, 2026SEC filing
Exercise or conversion

Andrew Reardon

CLO & Secretary

Employee Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$52.27 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded April 1, 2026Filed April 2, 2026SEC filing
Exercise or conversion

John L. Lamattina

Director

Common Stock

Value context
$246.68K
Reported price
$114.15 / share
Traded March 6, 2026Filed March 31, 2026SEC filing
Exercise or conversion

John L. Lamattina

Director

Non-Qualified Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$114.15 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded March 6, 2026Filed March 31, 2026SEC filing
Award disclosed

Octavio Espinoza

Chief Financial Officer

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded March 2, 2026Filed March 27, 2026SEC filing
Award disclosed

Octavio Espinoza

Chief Financial Officer

Employee Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded March 2, 2026Filed March 27, 2026SEC filing
Award disclosed

Todd C. Davis

Chief Executive Officer

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded March 2, 2026Filed March 27, 2026SEC filing
Award disclosed

Todd C. Davis

Chief Executive Officer

Employee Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded March 2, 2026Filed March 27, 2026SEC filing
Award disclosed

Andrew Reardon

CLO & Secretary

Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded March 2, 2026Filed March 27, 2026SEC filing
Award disclosed

Andrew Reardon

CLO & Secretary

Employee Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded March 2, 2026Filed March 27, 2026SEC filing
Reporting insiderSecurity / transactionAmount / priceValueTraded / disclosedSource
CLO & SecretaryCommon StockOption exercise or conversion10b5-1340$52.27 / share$17.77KOct 2Filed Oct 6 · 4d laterSEC filing
CLO & SecretaryEmployee Stock Option (right to buy)Option exercise or conversion10b5-1Derivative units340$52.27 exercise / conversion priceNot a separate purchaseOct 2Filed Oct 6 · 4d laterSEC filing
DirectorCommon StockExercise-price or tax withholding115$298.50 / share$34.33KSep 22Filed Sep 24 · 2d laterSEC filing
Chief Financial OfficerCommon StockOption exercise or conversion10b5-116,179$52.84 / share$854.9KAug 12Filed Aug 14 · 2d laterSEC filing
Chief Financial OfficerCommon StockOption exercise or conversion10b5-12,074$70.04 / share$145.26KAug 12Filed Aug 14 · 2d laterSEC filing
Chief Financial OfficerCommon StockOption exercise or conversion10b5-12,869$55.75 / share$159.95KAug 12Filed Aug 14 · 2d laterSEC filing
Chief Financial OfficerCommon StockOption exercise or conversion10b5-17,171$57.22 / share$410.32KAug 12Filed Aug 14 · 2d laterSEC filing
Chief Financial OfficerCommon StockOption exercise or conversion10b5-13,348$68.74 / share$230.14KAug 12Filed Aug 14 · 2d laterSEC filing
Chief Financial OfficerEmployee Stock Option (right to buy)Option exercise or conversion10b5-1Derivative units2,869$55.75 exercise / conversion priceNot a separate purchaseAug 12Filed Aug 14 · 2d laterSEC filing
Chief Financial OfficerEmployee Stock Option (right to buy)Option exercise or conversion10b5-1Derivative units7,171$57.22 exercise / conversion priceNot a separate purchaseAug 12Filed Aug 14 · 2d laterSEC filing
Chief Financial OfficerNon-Qualified Stock Option (right to buy)Option exercise or conversion10b5-1Derivative units16,179$52.84 exercise / conversion priceNot a separate purchaseAug 12Filed Aug 14 · 2d laterSEC filing
Chief Financial OfficerNon-Qualified Stock Option (right to buy)Option exercise or conversion10b5-1Derivative units3,348$68.74 exercise / conversion priceNot a separate purchaseAug 12Filed Aug 14 · 2d laterSEC filing
Chief Financial OfficerNon-Qualified Stock Option (right to buy)Option exercise or conversion10b5-1Derivative units2,074$70.04 exercise / conversion priceNot a separate purchaseAug 12Filed Aug 14 · 2d laterSEC filing
DirectorCommon StockOption exercise or conversion6,138$51.56 / share$316.48KAug 12Filed Aug 14 · 2d laterSEC filing
DirectorNon-Qualified Stock Option (right to buy)Option exercise or conversionDerivative units6,138$51.56 exercise / conversion priceNot a separate purchaseAug 12Filed Aug 14 · 2d laterSEC filing
CLO & SecretaryCommon StockOption exercise or conversion10b5-15,000$52.27 / share$261.35KAug 3Filed Aug 4 · 1d laterSEC filing
CLO & SecretaryEmployee Stock Option (right to buy)Option exercise or conversion10b5-1Derivative units5,000$52.27 exercise / conversion priceNot a separate purchaseAug 3Filed Aug 4 · 1d laterSEC filing
CLO & SecretaryCommon StockOther transaction10b5-1132$160.71 / share$21.21KJun 30Filed Jul 6 · 6d laterSEC filing
CLO & SecretaryCommon StockOption exercise or conversion10b5-15,000$52.27 / share$261.35KJul 1Filed Jul 6 · 5d laterSEC filing
CLO & SecretaryEmployee Stock Option (right to buy)Option exercise or conversion10b5-1Derivative units5,000$52.27 exercise / conversion priceNot a separate purchaseJul 1Filed Jul 6 · 5d laterSEC filing
Chief Financial OfficerCommon StockOther transaction17$160.71 / share$2.73KJun 30Filed Jul 6 · 6d laterSEC filing
Chief Executive OfficerCommon StockOther transaction132$160.71 / share$21.21KJun 30Filed Jul 6 · 6d laterSEC filing
DirectorCommon StockOption exercise or conversion2,145$66.13 / share$141.85KJun 16Filed Jun 18 · 2d laterSEC filing
DirectorNon-Qualified Stock Option (right to buy)Option exercise or conversionDerivative units2,145$66.13 exercise / conversion priceNot a separate purchaseJun 16Filed Jun 18 · 2d laterSEC filing
DirectorCommon StockOption exercise or conversion3,000$51.56 / share$154.68KJun 12Filed Jun 15 · 3d laterSEC filing
DirectorCommon StockOption exercise or conversion1,000$51.56 / share$51.56KJun 12Filed Jun 15 · 3d laterSEC filing
DirectorNon-Qualified Stock Option (right to buy)Option exercise or conversionDerivative units3,000$51.56 exercise / conversion priceNot a separate purchaseJun 12Filed Jun 15 · 3d laterSEC filing
DirectorNon-Qualified Stock Option (right to buy)Option exercise or conversionDerivative units1,000$51.56 exercise / conversion priceNot a separate purchaseJun 12Filed Jun 15 · 3d laterSEC filing
DirectorCommon StockGrant or award836Award · no purchase priceNon-cash awardJun 5Filed Jun 12 · 7d laterSEC filing
DirectorNon-Qualified Stock Option (right to buy)Grant or awardDerivative units2,938Award · no purchase priceNon-cash awardJun 5Filed Jun 12 · 7d laterSEC filing
DirectorCommon StockGrant or award836Award · no purchase priceNon-cash awardJun 5Filed Jun 9 · 4d laterSEC filing
DirectorCommon StockExercise-price or tax withholding182$237.00 / share$43.13KJun 5Filed Jun 9 · 4d laterSEC filing
DirectorNon-Qualified Stock Option (right to buy)Grant or awardDerivative units2,938Award · no purchase priceNon-cash awardJun 5Filed Jun 9 · 4d laterSEC filing
DirectorCommon StockGrant or award836Award · no purchase priceNon-cash awardJun 5Filed Jun 9 · 4d laterSEC filing
DirectorNon-Qualified Stock Option (right to buy)Grant or awardDerivative units2,938Award · no purchase priceNon-cash awardJun 5Filed Jun 9 · 4d laterSEC filing
DirectorCommon StockGrant or award836Award · no purchase priceNon-cash awardJun 5Filed Jun 9 · 4d laterSEC filing
DirectorNon-Qualified Stock Option (right to buy)Grant or awardDerivative units2,938Award · no purchase priceNon-cash awardJun 5Filed Jun 9 · 4d laterSEC filing
DirectorCommon StockGrant or award836Award · no purchase priceNon-cash awardJun 5Filed Jun 9 · 4d laterSEC filing
DirectorNon-Qualified Stock Option (right to buy)Grant or awardDerivative units2,938Award · no purchase priceNon-cash awardJun 5Filed Jun 9 · 4d laterSEC filing
DirectorCommon StockGrant or award836Award · no purchase priceNon-cash awardJun 5Filed Jun 9 · 4d laterSEC filing
DirectorNon-Qualified Stock Option (right to buy)Grant or awardDerivative units2,938Award · no purchase priceNon-cash awardJun 5Filed Jun 9 · 4d laterSEC filing
DirectorCommon StockGrant or award836Award · no purchase priceNon-cash awardJun 5Filed Jun 9 · 4d laterSEC filing
DirectorNon-Qualified Stock Option (right to buy)Grant or awardDerivative units2,938Award · no purchase priceNon-cash awardJun 5Filed Jun 9 · 4d laterSEC filing
CLO & SecretaryCommon StockOption exercise or conversion10b5-15,000$52.27 / share$261.35KJun 1Filed Jun 2 · 1d laterSEC filing
CLO & SecretaryEmployee Stock Option (right to buy)Option exercise or conversion10b5-1Derivative units5,000$52.27 exercise / conversion priceNot a separate purchaseJun 1Filed Jun 2 · 1d laterSEC filing
Chief Financial OfficerCommon StockOption exercise or conversion764$63.62 / share$48.61KMay 27Filed May 28 · 1d laterSEC filing
Chief Financial OfficerCommon StockOption exercise or conversion972$52.84 / share$51.36KMay 27Filed May 28 · 1d laterSEC filing
Chief Financial OfficerEmployee Stock Option (right to buy)Option exercise or conversionDerivative units972$52.84 exercise / conversion priceNot a separate purchaseMay 27Filed May 28 · 1d laterSEC filing
Chief Financial OfficerEmployee Stock Option (right to buy)Option exercise or conversionDerivative units764$63.62 exercise / conversion priceNot a separate purchaseMay 27Filed May 28 · 1d laterSEC filing
DirectorCommon StockOption exercise or conversion10b5-1459$69.51 / share$31.91KMay 12Filed May 14 · 2d laterSEC filing
DirectorCommon StockOption exercise or conversion10b5-11,575$69.51 / share$109.48KMay 13Filed May 14 · 1d laterSEC filing
DirectorNon-Qualified Stock Option (right to buy)Option exercise or conversion10b5-1Derivative units459$69.51 exercise / conversion priceNot a separate purchaseMay 12Filed May 14 · 2d laterSEC filing
DirectorNon-Qualified Stock Option (right to buy)Option exercise or conversion10b5-1Derivative units1,575$69.51 exercise / conversion priceNot a separate purchaseMay 13Filed May 14 · 1d laterSEC filing
CLO & SecretaryCommon StockOption exercise or conversion10b5-15,000$52.27 / share$261.35KMay 1Filed May 4 · 3d laterSEC filing
CLO & SecretaryEmployee Stock Option (right to buy)Option exercise or conversion10b5-1Derivative units5,000$52.27 exercise / conversion priceNot a separate purchaseMay 1Filed May 4 · 3d laterSEC filing
CLO & SecretaryCommon StockOption exercise or conversion10b5-15,000$52.27 / share$261.35KApr 1Filed Apr 2 · 1d laterSEC filing
CLO & SecretaryEmployee Stock Option (right to buy)Option exercise or conversion10b5-1Derivative units5,000$52.27 exercise / conversion priceNot a separate purchaseApr 1Filed Apr 2 · 1d laterSEC filing
DirectorCommon StockOption exercise or conversion2,161$114.15 / share$246.68KMar 6Filed Mar 31 · 25d laterSEC filing
DirectorNon-Qualified Stock Option (right to buy)Option exercise or conversionDerivative units2,161$114.15 exercise / conversion priceNot a separate purchaseMar 6Filed Mar 31 · 25d laterSEC filing
Chief Financial OfficerCommon StockGrant or award4,933Award · no purchase priceNon-cash awardMar 2Filed Mar 27 · 25d laterSEC filing
Chief Financial OfficerEmployee Stock Option (right to buy)Grant or awardDerivative units23,527Award · no purchase priceNon-cash awardMar 2Filed Mar 27 · 25d laterSEC filing
Chief Executive OfficerCommon StockGrant or award10,495Award · no purchase priceNon-cash awardMar 2Filed Mar 27 · 25d laterSEC filing
Chief Executive OfficerEmployee Stock Option (right to buy)Grant or awardDerivative units50,058Award · no purchase priceNon-cash awardMar 2Filed Mar 27 · 25d laterSEC filing
CLO & SecretaryCommon StockGrant or award4,513Award · no purchase priceNon-cash awardMar 2Filed Mar 27 · 25d laterSEC filing
CLO & SecretaryEmployee Stock Option (right to buy)Grant or awardDerivative units21,525Award · no purchase priceNon-cash awardMar 2Filed Mar 27 · 25d laterSEC filing

Congress transactions 4

All Congress filings
Purchase disclosed

Ligand Pharmaceuticals Incorporated - Common Stock (LGND) · Stock

The filing reports a purchase for the member.

Gilbert Cisneros official portraitGilbert CisnerosReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
May 29, 2026
Filed June 8, 2026 · 10d laterOriginal report
Purchase disclosed

Ligand Pharmaceuticals Incorporated - Common Stock (LGND) · Stock

The filing reports a purchase for the member.

Gilbert Cisneros official portraitGilbert CisnerosReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
March 3, 2026
Filed April 7, 2026 · 35d laterOriginal report
Purchase disclosed

Ligand Pharmaceuticals Incorporated - Common Stock (LGND) · Stock

The filing reports a purchase for the member.

Gilbert Cisneros official portraitGilbert CisnerosReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
January 15, 2026
Filed February 13, 2026 · 29d laterOriginal report
Purchase disclosed

Ligand Pharmaceuticals Incorporated - Common Stock (LGND) · Stock

The filing reports a purchase for the member.

Gilbert Cisneros official portraitGilbert CisnerosReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
January 5, 2026
Filed February 13, 2026 · 39d laterOriginal report
Explore furtherTechnical lab Company financials Test a strategy Compare company

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage
Source
SEC EDGAR · Form 4
Issuer CIK
0000886163
Latest public acceptance
Oct 6, 2026, 08:35 PM UTC
Score calculated
Oct 8, 2026, 12:04 AM UTC
Parser
form4-parser-1.5
Classifier
form4-classifier-1.1
Scoring methodology
insider-experimental-1.1
Availability
Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.